Favipiravir Tablet 200 mg, 400 mg, 600 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 200 mg, 400 mg, 600 mg
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
Category: Anti Covid Medicines
Favipiravir, an antiviral used for mild to moderate COVID-19, is approved in countries like India, Japan, and Russia, under brands such as Fabiflu, Avigan, and Avifavir. Though not approved in the US or EU, it's widely sourced across Asia, LATAM, and MENA. PharmaB2B platforms connect buyers with trusted Favipiravir exporters and manufacturers, offering bulk supply, global reach, and regulatory-compliant sourcing.
Product Description: Favipiravir is a broad-spectrum antiviral used in the treatment of mild to moderate COVID-19 in countries like India, Japan, Russia, and Bangladesh. Commonly available in 200 mg and 400 mg tablets, it is marketed under leading brands such as Fabiflu, Avigan, and Avifavir. While not approved in the US or EU, Favipiravir remains in demand across Asia, the Middle East, and Latin America. Global PharmaB2B platforms connect verified Favipiravir suppliers, manufacturers, and exporters, ensuring regulatory-compliant sourcing, competitive pricing, and bulk availability. Partner with trusted B2B pharmaceutical networks for efficient distribution and international trade.
Favipiravir Tablet — third party manufacturing & bulk supply
Favipiravir Tablet 200 mg, 400 mg, 600 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Favipiravir Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Favipiravir Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Favipiravir Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Nirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Quick Response Guaranteed | Verified Suppliers
